Corporacion de Beneficencia Osorno
About Corporacion de Beneficencia Osorno
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
2
Pfizer
2
Cogentus Pharmaceuticals
1
EMD Serono
1
EMD Serono Research & Development Institute, Inc.
1
Zymeworks Inc.
1
Clinical Trials at Corporacion de Beneficencia Osorno
During the past decade, Corporacion de Beneficencia Osorno conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 6 clinical trials were completed, i.e. on
average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)
2007-12-01
2009-11-01
Terminated
5,000
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
Long-term Safety and Tolerability of Atacicept (Long-term Follow-Up of Participant Who Participated in ADDRESS II)
2014-07-29
2018-02-09
Terminated
253
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
2015-01-26
2016-10-18
Completed
645
Long-term Assessment of Safety and Efficacy of BI 695501 in Patients With Rheumatoid Arthritis
2016-01-22
2017-11-01
Completed
430
A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers
2021-12-02
2025-07-01
Recruiting
714
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Corporacion de Beneficencia Osorno" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Pfizer" with 2 trials
sponsored, "Cogentus Pharmaceuticals" with 1 trials sponsored, "EMD Serono" with 1 trials sponsored and "EMD Serono Research & Development Institute, Inc."
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Corporacion de Beneficencia Osorno"
#1 collaborator was "BeiGene, Ltd." with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Corporacion de Beneficencia Osorno
According to Clinical.Site data, the most researched conditions in "Corporacion de Beneficencia Osorno" are
"Arthritis, Rheumatoid" (2 trials), "Cardiovascular Disease" (2 trials), "Acute Coronary Syndrome" (1 trials), "Coronary Artery Disease" (1 trials) and "Esophageal Adenocarcinoma" (1 trials). Many other conditions were trialed in "Corporacion de Beneficencia Osorno" in a lesser frequency.
Clinical Trials Intervention Types at Corporacion de Beneficencia Osorno
Most popular intervention types in "Corporacion de Beneficencia Osorno" are "Drug" (8 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "BI 695501" (2 trials), "bococizumab (PF-04950615)" (2 trials), "5-Fluorouracil" (1 trials) and "Atacicept 150 mg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Corporacion de Beneficencia Osorno
The vast majority of trials in "Corporacion de Beneficencia Osorno" are
8 trials for "All" genders.
Clinical Trials Status at Corporacion de Beneficencia Osorno
Currently, there are NaN active trials in "Corporacion de Beneficencia Osorno".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Corporacion de Beneficencia Osorno,
undefined suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Corporacion de Beneficencia Osorno, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".